When was Merieux Equity Partners founded?

Merieux Equity Partners was founded in 2009.

Where is Merieux Equity Partners' headquarters located?

Merieux Equity Partners' headquarters is located in Lyon (France).

How big is Merieux Equity Partners' investment team?

Merieux Equity Partners has a team of 28, including 11 partners.

How many companies has Merieux Equity Partners invested in?

Merieux Equity Partners has invested in 66 companies, including Ceva & Twist Bioscience.

Which companies has Merieux Equity Partners invested in lately?

HighLife Medical & Amyl Therapeutics are the latest investments by Merieux Equity Partners.

Merieux Equity Partners - 2026 Investor Profile, Portfolio, Team & Exits

Merieux Equity Partners is a private equity firm founded in 2009. It is primarily based in Lyon, France. As of Sep 2026, Merieux Equity Partners is an active investor with a portfolio of 66 companies, comprising 66 funding rounds and 7 acquisitions. In the last 12 months, it has participated in 3 funding rounds. The firm primarily invests in companies based in France and United States. Its portfolio is spread across a wide range of sectors from Life Sciences to Healthcare. Its latest investment was a $***** Series C round in HighLife Medical on Sep 22, 2026 which also saw participation from Andera Partners, Sofinnova Partners and other investors.

A lot of funds co-invest with Merieux Equity Partners, with names like Supernova Invest sharing a substantial percentage of its portfolio.

Merieux Equity Partners has a team of 28 people, including 11 partners.

Key Metrics

Founded Year

2009

Location

Lyon, France

Portfolio Companies

Ceva, Twist Bioscience & 64 more

Portfolio Sectors

Life Sciences, Healthcare

Portfolio Locations

France, United States & 9 more

Acquisition Deals

Curea medical, InnoSyn & 5 more

Investment Deals

Ceva, Twist Bioscience & 64 more

View Merieux Equity Partners's full profile

Merieux Equity Partners has a portfolio of 66 companies. They have invested in a total of 66 companies. Their most recent investment was in HighLife Medical (Series C round) on Sep 22, 2026. Here are the most recent investments by Merieux Equity Partners:

Date	Company	Round	Amount	Co-Investors
Sep 22, 2026	HighLife Medical	Series C	7129	Andera Partners and 11 others
Sep 01, 2026	Amyl Therapeutics	Series A	9139	Noshaq
Jun 04, 2026	Ona Therapeutics	Series B	9282	Columbus Venture Partners ... and 8 others
May 26, 2025	SeqOne	Series A	5327	Supernova Invest and 2 others

View all investments by Merieux Equity Partners

Merieux Equity Partners has acquired 7 companies. Their most recent acquisition was of Curea medical on Mar 21, 2025. Here are the most recent acquisitions by Merieux Equity Partners:

Acquisition Date	Company	Short Description	Total Funding	Founded Year
Mar 21, 2025	Curea medical	Developer of solution for wound dressing	-	2010
Feb 08, 2024	InnoSyn	Provides research and development of chemical processes	-	2017
Dec 04, 2023	Labquality	Provider of quality services for healthcare, pharmaceutical, and medical industries with expertise in healthcare and health-tech quality	-	1971
Jan 12, 2021	Plantex	Manufacturer of plant based nutraceutical, dietary, animal nutritional, and cosmetic products	-	1990

Here is the portfolio snapshot of Merieux Equity Partners:

Investments by Year

The maximum number of investments were made in 2022

Acquisitions by Year

The maximum number of acquisitions were made in 2019

Portfolio by Location

Companies are primarily in France and United States

Portfolio by Sector

Companies are primarily in Life Sciences

Merieux Equity Partners has a team of 28 members including 11 Partners located in France, Portugal and 1 more location. Merieux Equity Partners' team does not sit on the board of any company as of now.

Here is a list of top team members in Merieux Equity Partners:

Name	Designation	Location	Board Memberships	Contact Details
Quentin De Labarre	Partner	Paris	-	1 Email
Valerie Calenda	Partner	Lyon	-	1 Email
Christine Demode	Partner	Lyon	-	2 Emails
Emna Bourkhis	Partner	Paris	-	-
Yoann Bonnamour	Partner	Lyon	-	2 Emails
Theodor Wuppermann	Partner	Paris	-	1 Email
Pierre A Morgon	Partner	Lausanne	-	-
Jean-Guillaume Lafay	Partner	-	-	-
Francois Rosenfeld	Partner	-	-	1 Email
Florent Rosset	Partner	France	-	1 Email

View team details of Merieux Equity Partners

Over the past 17 years, 92 investors have co-invested in Merieux Equity Partners's portfolio companies.

Top Co-investors of Merieux Equity Partners: 92 investors entered a company along with Merieux Equity Partners. These include investors like Supernova Invest (4 companies).

View the list of Co-Investors of Merieux Equity Partners

•

HighLife Secures Over $90 Million Funding to Support US Clinical Study and European ExpansionYahoo•Sep 22, 2026•Merieux Equity Partners, Andera Partners, Supernova Invest, HighLife Medical

•

Ona Therapeutics Secures 74 Million Euros to Advance Oncology Drug DevelopmentExpansion•Jun 04, 2026•Ona Therapeutics, Columbus Venture Partners, Merieux Equity Partners, Cuatrecasas and 6 others

•

Alantra PE raises 155 million for a continuation fund to support Health in CodePressDigital•Feb 12, 2026•Alantra, Merieux Equity Partners, Hayfin, Health in Code

•

French Venture Studio M2care Secures €26 Million Funding RoundStartup Rise EU•Sep 03, 2025•Bpifrance, M2care, Merieux Equity Partners, Credit Agricole and 1 other

•

Swiss MedTech startup Rhovica raises €2.5 million for emergency neurosurgical deviceEU-Startups•Aug 26, 2025•Rhovica, M2care, Kickfund, ValueMaker and 4 others

•